Literature DB >> 21749281

In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile.

Morgan M Martin1, Stephanie A Condotta, Jeremy Fenn, Andrea D Olmstead, François Jean.   

Abstract

The need to identify anti-Flaviviridae agents has resulted in intensive biochemical study of recombinant nonstructural (NS) viral proteases; however, experimentation on viral protease-associated replication complexes in host cells is extremely challenging and therefore limited. It remains to be determined if membrane anchoring and/or association to replicase-membrane complexes of proteases, such as hepatitis C virus (HCV) NS3-4A, plays a regulatory role in the substrate selectivity of the protease. In this study, we examined trans-endoproteolytic cleavage activities of membrane-anchored and replicase-associated NS3-4A using an internally consistent set of membrane-anchored protein substrates mimicking all known HCV NS3-4A polyprotein cleavage sequences. Interestingly, we detected cleavage of substrates encoding for the NS4B/NS5A and NS5A/NS5B junctions, but not for the NS3/NS4A and NS4A/NS4B substrates. This stringent substrate recognition profile was also observed for the replicase-associated NS3-4A and is not genotype-specific. Our study also reveals that ER-anchoring of the substrate is critical for its cleavage by NS3-4A. Importantly, we demonstrate that in HCV-infected cells, the NS4B/NS5A substrate was cleaved efficiently. The unique ability of our membrane-anchored substrates to detect NS3-4A activity alone, in replication complexes, or within the course of infection, shows them to be powerful tools for drug discovery and for the study of HCV biology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21749281     DOI: 10.1515/BC.2011.076

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  2 in total

1.  Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents.

Authors:  Andrea D Olmstead; Wolfgang Knecht; Ina Lazarov; Surjit B Dixit; François Jean
Journal:  PLoS Pathog       Date:  2012-01-05       Impact factor: 6.823

2.  New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay.

Authors:  Sergey A Shiryaev; Elliot R Thomsen; Piotr Cieplak; Eugene Chudin; Anton V Cheltsov; Mark S Chee; Igor A Kozlov; Alex Y Strongin
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.